School of Kinesiology, University of Minnesota, Minneapolis, MN 55455, USA.
Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
J Card Fail. 2020 Aug;26(8):645-651. doi: 10.1016/j.cardfail.2020.01.011. Epub 2020 Jan 23.
Methods for reducing major adverse cardiac events (MACE) in patients after heart transplantation (HTx) are critical for long-term quality outcomes.
Patients with cardiopulmonary exercise testing prior to HTx and at least 1 session of cardiac rehabilitation (CR) after HTx were included. Exercise sessions were evaluated as ≥ 23 or < 23 sessions based on recursive partitioning. We included 140 patients who had undergone HTx (women: n = 41 (29%), age: 52 ± 12 years, body mass index: 27 ± 5 kg/m). Mean follow-up was 4.1 ± 2.7 years, and 44 patients (31%) had a MACE: stroke (n = 1), percutaneous intervention (n = 5), heart failure (n = 6), myocardial infarction (n = 1), rejection (n = 16), or death (n = 15). CR was a significant predictor of MACE, with ≥ 23 sessions associated with a ∼ 60% reduction in MACE risk (hazard ratio [HR]: 0.42, 95% CI: 0.19-0.94, P = 0.035). This remained after adjusting for age, sex and history of diabetes (HR: 0.41, 95% CI: 0.18-0.94, P = 0.035) as well as body mass index and pre-HTx peak oxygen consumption (HR: 0.40, 95% CI: 0.18-0.92, P = 0.031).
After adjustment for covariates of age, sex, diabetes, body mass index, and pre-HTx peak oxygen consumption, CR attendance of ≥ 23 exercise sessions was predictive of lower MACE risk following HTx. In post-HTx patients, CR was associated with MACE prevention and should be viewed as a critical tool in post-HTx treatment strategies.
对于心脏移植(HTx)后患者的重大不良心脏事件(MACE)的降低方法,对长期质量结果至关重要。
纳入了在 HTx 前进行心肺运动测试且在 HTx 后至少进行 1 次心脏康复(CR)的患者。根据递归分区,将运动次数评估为≥23 次或<23 次。我们纳入了 140 名接受 HTx 的患者(女性:n=41(29%),年龄:52±12 岁,体重指数:27±5 kg/m)。平均随访时间为 4.1±2.7 年,有 44 名患者(31%)发生 MACE:中风(n=1),经皮介入(n=5),心力衰竭(n=6),心肌梗死(n=1),排斥(n=16)或死亡(n=15)。CR 是 MACE 的显著预测因素,≥23 次的 CR 与 MACE 风险降低约 60%相关(风险比 [HR]:0.42,95%置信区间:0.19-0.94,P=0.035)。在调整年龄、性别和糖尿病史(HR:0.41,95%置信区间:0.18-0.94,P=0.035)以及体重指数和 HTx 前峰值摄氧量(HR:0.40,95%置信区间:0.18-0.92,P=0.031)后,这一结果仍然存在。
在调整年龄、性别、糖尿病、体重指数和 HTx 前峰值摄氧量等协变量后,接受≥23 次 CR 的患者预测 HTx 后发生 MACE 的风险较低。在 HTx 后患者中,CR 与 MACE 的预防有关,应将其视为 HTx 后治疗策略的重要工具。